{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T10:15:06Z","timestamp":1768731306567,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MEDICAL RESEARCH COUNCIL","award":["G0100137"],"award-info":[{"award-number":["G0100137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12905-019-0761-y","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T11:14:27Z","timestamp":1557314067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection"],"prefix":"10.1186","volume":"19","author":[{"given":"Resha","family":"Boodhram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1849-9631","authenticated-orcid":false,"given":"Dhayendre","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathlee","family":"Abbai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Ramjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"761_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS. UNAIDS data 2017. Geneva, Switzerland: UNAIDS, 2017."},{"key":"761_CR2","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.18.2.19408","volume":"18","author":"RC Dellar","year":"2015","unstructured":"Dellar RC, Dlamini S, Abdool Karim Q. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc. 2015;18(2Suppl 1:19408.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"761_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153969","volume":"11","author":"G Ramjee","year":"2016","unstructured":"Ramjee G, Moonsamy S, Abbai NS, Wand H. Individual and population level impact of key HIV risk factors on HIV incidence rates in Durban, South Africa. PLoS One. 2016;11(4):e0153969.","journal-title":"PLoS One"},{"issue":"2","key":"761_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/QAI.0000000000001656","volume":"78","author":"B Maughan-Brown","year":"2018","unstructured":"Maughan-Brown B, George G, Beckett S, et al. HIV risk among adolescent girls and young women in age-disparate partnerships: evidence from KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2018;78(2):155\u201362.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"761_CR5","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s10461-015-1002-5","volume":"19","author":"N Naicker","year":"2015","unstructured":"Naicker N, Kharsany AB, Werner L, et al. Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting. AIDS Behav. 2015;19(7):1305\u201316.","journal-title":"AIDS Behav"},{"issue":"2","key":"761_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/civ298","volume":"61","author":"L Masson","year":"2015","unstructured":"Masson L, Passmore JA, Liebenberg LJ, et al. Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis. 2015;61(2):260\u20139.","journal-title":"Clin Infect Dis"},{"key":"761_CR7","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.18.1.19866","volume":"18","author":"H Wand","year":"2015","unstructured":"Wand H, Ramjee G. Biological impact of recurrent sexually transmitted infections on HIV seroconversion among women in South Africa: results from frailty models. J Int AIDS Soc. 2015;18:19866.","journal-title":"J Int AIDS Soc"},{"key":"761_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-016-0295-5","volume":"16","author":"NS Abbai","year":"2016","unstructured":"Abbai NS, Wand H, Ramjee G. Biological factors that place women at risk for HIV: evidence from a large-scale clinical trial in Durban. BMC Womens Health. 2016;16:19. \n                    https:\/\/doi.org\/10.1186\/s12905-016-0295-5\n                    \n                  .","journal-title":"BMC Womens Health"},{"issue":"1","key":"761_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12981-017-0169-4","volume":"14","author":"D Vitali","year":"2017","unstructured":"Vitali D, Wessels JM, Kaushic C. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract. AIDS Res Ther. 2017;14(1):39.","journal-title":"AIDS Res Ther"},{"issue":"1\u20132","key":"761_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jsbmb.2012.02.001","volume":"132","author":"E Cabrera-Munoz","year":"2012","unstructured":"Cabrera-Munoz E, Fuentes-Romero LL, Zamora-Ch\u00e1vez J, Camacho-Arroyo I, Soto-Ram\u00edrez LE. Effects of progesterone on the content of CCR5 and CXCR4 coreceptors in PBMCs of seropositive and exposed but uninfected Mexican women to HIV-1. J Steroid Biochem Mol Biol. 2012;132(1\u20132):66\u201372.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"761_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1530\/JME-16-0138","volume":"57","author":"V Ragupathy","year":"2016","unstructured":"Ragupathy V, Xue W, Tan J, Devadas K, Gao Y, Hewlett I. Progesterone augments cell susceptibility to HIV-1 and HIV-1\/HSV-2 co-infections. J Mol Endocrinol. 2016;57(3):185\u201399.","journal-title":"J Mol Endocrinol"},{"key":"761_CR12","doi-asserted-by":"publisher","first-page":"8793","DOI":"10.1128\/JVI.00756-15","volume":"89","author":"K Birse","year":"2015","unstructured":"Birse K, Arnold KB, et al. Molecular signatures of immune activation and epithelial barrier Remodelling are enhanced during the luteal phase of the menstrual cycle: implication for HIV susceptibility. J Virol. 2015;89:8793\u2013805.","journal-title":"J Virol"},{"issue":"5","key":"761_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/jmp.12124","volume":"43","author":"EN Kersh","year":"2014","unstructured":"Kersh EN, Henning T, Vishwanathan SA, et al. SHIV susceptibility changes during the menstrual cycle of pigtail macaques. J Med Primatol. 2014 Oct;43(5):310\u20136.","journal-title":"J Med Primatol"},{"issue":"4","key":"761_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/QAI.0b013e318220ebd3","volume":"57","author":"SA Vishwanathan","year":"2011","unstructured":"Vishwanathan SA, Guenthner P, Lin CY, et al. High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr. 2011;57(4):261\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"761_CR15","first-page":"S2352","volume":"15","author":"LM Noguchi","year":"2015","unstructured":"Noguchi LM, Richardson BA, Baeten JM, et al. Risk of HIV-1 acquisition among women who use different types of progestin contraception in South Africa: a prospective cohort study. Lancet. 2015;15:S2352\u20133018.","journal-title":"Lancet."},{"key":"761_CR16","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1097\/QAD.0000000000001228","volume":"30","author":"CB Polis","year":"2016","unstructured":"Polis CB, Curtis KM, Hannaford PC, et al. Update on hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. AIDS. 2016;30:2665\u201383.","journal-title":"AIDS"},{"issue":"4","key":"761_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(15)00429-6","volume":"16","author":"EH Byrne","year":"2016","unstructured":"Byrne EH, Anahtar MN, Cohen KE, et al. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in south African women: a prospective cohort study. Lancet Infect Dis. 2016;16(4):441\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"9749","key":"761_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","volume":"376","author":"Sheena McCormack","year":"2010","unstructured":"McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (microbicides development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(10)61086-0\n                    \n                  .","journal-title":"The Lancet"},{"issue":"5","key":"761_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/QAI.0b013e31827e8f98","volume":"15:62","author":"NK Landolt","year":"2013","unstructured":"Landolt NK, Phanuphak N, Ubolyam S, et al. Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels when coadministered with combined oral contraceptives. J Acquir Immune Defic Syndr. 2013;15:62(5):534\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"761_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cct.2016.11.006","volume":"52","author":"AP Kourtis","year":"2017","unstructured":"Kourtis AP, Haddad L, Tang J, et al. A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: addressing evolving research priorities. Contemp Clin Trials. 2017;52:27\u201334.","journal-title":"Contemp Clin Trials"},{"issue":"9","key":"761_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005885","volume":"12","author":"AM Carias","year":"2016","unstructured":"Carias AM, Allen SA, Fought AJ, et al. Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract. PLoS Pathog. 2016;12(9):e1005885.","journal-title":"PLoS Pathog"},{"issue":"3","key":"761_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1677\/joe.1.06873","volume":"190","author":"B Poonia","year":"2006","unstructured":"Poonia B, Walter L, Dufour J, Harrison R, Marx PA, Veazey RS. Cyclic changes in the vaginal epithelium of normal rhesus macaques. J Endocrinol. 2006;190(3):829\u201335.","journal-title":"J Endocrinol"},{"issue":"Suppl 1","key":"761_CR23","first-page":"S125","volume":"14","author":"S Hild-Petito","year":"1998","unstructured":"Hild-Petito S, Veazey RS, Larner JM, Reel JR, Blye RP. Effects of two progestin-only contraceptives, depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys. AIDS Res Hum Retro. 1998;14(Suppl 1):S125\u201330.","journal-title":"AIDS Res Hum Retro"},{"issue":"8","key":"761_CR24","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/humrep\/deu113","volume":"29","author":"AM Crook","year":"2014","unstructured":"Crook AM, Ford D, Gafos M, et al. Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial. Hum Reprod. 2014;29(8):1810\u20137.","journal-title":"Hum Reprod"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-019-0761-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-019-0761-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-019-0761-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T23:11:05Z","timestamp":1588806665000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-019-0761-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["761"],"URL":"https:\/\/doi.org\/10.1186\/s12905-019-0761-y","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"14 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed by the Biomedical Research Ethics Committee (BREC) of the University of KwaZulu-Natal and full ethical approval granted on 16 September 2015 (BE352\/15). This study was a retrospective analysis utilizing stored serum samples from women who had participated in the Microbicides Development Programme (MDP) 301 trial conducted between 2005 and 2009. In the parent study, written informed consent was obtained for long term storage and future testing of specimens.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"63"}}